THE INFLUENCE OF THE SPARTEINE DEBRISOQUIN PHENOTYPE ON THE DISPOSITION OF FLECAINIDE

被引：64

作者：

MIKUS, G

GROSS, AS

BECKMANN, J

HERTRAMPF, R

GUNDERTREMY, U

EICHELBAUM, M

机构：

[1] DR MARGARETE FISCHERBOSCH INST KLIN PHARMAKOL,AUERBACHSTR 112,D-7000 STUTTGART 50,FED REP GER

[2] BUNDESGESUNDHEITSAMT,INST ARZNEIMITTEL,D-1000 BERLIN 33,FED REP GER

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1989年 / 45卷 / 05期

关键词：

D O I：

10.1038/clpt.1989.73

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：562 / 567

页数：6

共 24 条

[1] PHARMACOKINETICS OF FLECAINIDE IN PATIENTS WITH MILD AND MODERATE RENAL-FAILURE COMPARED WITH PATIENTS WITH NORMAL RENAL-FUNCTION [J].

BRAUN, J ;

KOLLERT, JR ;

BECKER, JU .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 31 (06) :711-714

[2] FLECAINIDE HALF-LIFE PROLONGATION IN 2 PATIENTS WITH CONGESTIVE HEART-FAILURE AND COMPLEX VENTRICULAR ARRHYTHMIAS [J].

CAVALLI, A ;

MAGGIONI, AP ;

MARCHI, S ;

VOLPI, A ;

LATINI, R .

CLINICAL PHARMACOKINETICS, 1988, 14 (03) :187-188

[3] APPLICATION OF A BONDED-PHASE EXTRACTION COLUMN FOR RAPID SAMPLE PREPARATION OF FLECAINIDE FROM HUMAN-PLASMA FOR HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS - FLUORESCENCE OR ULTRAVIOLET DETECTION [J].

CHANG, SF ;

MILLER, AM ;

FOX, JM ;

WELSCHER, TM .

THERAPEUTIC DRUG MONITORING, 1984, 6 (01) :105-111

[4] METABOLISM OF FLECAINIDE [J].

CONARD, GJ ;

OBER, RE .

AMERICAN JOURNAL OF CARDIOLOGY, 1984, 53 (05) :B41-B51

[5] INFLUENCE OF THE DEFECTIVE METABOLISM OF SPARTEINE ON ITS PHARMACOKINETICS [J].

EICHELBAUM, M ;

SPANNBRUCKER, N ;

DENGLER, HJ .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (03) :189-194

[6] POLYMORPHIC OXIDATION OF SPARTEINE AND DEBRISOQUINE - RELATED PHARMACOGENETIC ENTITIES [J].

EICHELBAUM, M ;

BERTILSSON, L ;

SAWE, J ;

ZEKORN, C .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (02) :184-186

[7] ORAL FLECAINIDE PHARMACOKINETICS IN PATIENTS WITH IMPAIRED RENAL-FUNCTION [J].

FORLAND, SC ;

BURGESS, E ;

BLAIR, AD ;

CUTLER, RE ;

KVAM, DC ;

WEEKS, CE ;

FOX, JM ;

CONARD, GJ .

JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 28 (03) :259-267

[8] EXTRACARDIAC ADVERSE-EFFECTS OF FLECAINIDE [J].

GENTZKOW, GD ;

SULLIVAN, JY .

AMERICAN JOURNAL OF CARDIOLOGY, 1984, 53 (05) :B101-B105

[9] CHARACTERIZATION OF THE COMMON GENETIC-DEFECT IN HUMANS DEFICIENT IN DEBRISOQUINE METABOLISM [J].

GONZALEZ, FJ ;

SKODA, RC ;

KIMURA, S ;

UMENO, M ;

ZANGER, UM ;

NEBERT, DW ;

GELBOIN, HV ;

HARDWICK, JP ;

MEYER, UA .

NATURE, 1988, 331 (6155) :442-446

[10] FLECAINIDE - A PRELIMINARY REVIEW OF ITS PHARMACODYNAMIC PROPERTIES AND THERAPEUTIC EFFICACY [J].

HOLMES, B ;

HEEL, RC .

DRUGS, 1985, 29 (01) :1-33

← 1 2 3 →